In Stock
Tesamorelin 5 MG research peptide vial — myPEPT EU — Halloween 2026 light

Tesamorelin is a 44-amino-acid synthetic analog of growth hormone-releasing hormone (GHRH), with an added trans-3-hexenoic acid group that increases its stability compared to native GHRH. It acts on the GHRH receptor in the anterior pituitary to stimulate endogenous GH secretion, and has been used in both clinical and pre-clinical research contexts to study GHRH receptor pharmacology.

Research has investigated Tesamorelin's pharmacokinetics in relation to GH pulse stimulation, its receptor binding characteristics, and how GHRH agonism influences downstream IGF-1 signaling in pre-clinical endocrine models. Studies have also examined how its extended stability profile compared to native GHRH affects duration of receptor activation and GH secretion dynamics, making it a useful research tool for characterizing GHRH receptor responses.

Tesamorelin has also been investigated in models examining visceral adipose tissue biology, where GH signaling plays a regulatory role in lipid metabolism pathways — an area that has made it a compound of interest in both endocrinology and metabolic research settings.

myPEPT supplies Tesamorelin at ≥99% verified purity with a Certificate of Analysis from independent third-party lab testing. Lyophilized and shipped across the EU in research-grade packaging.

What researchers should know: Tesamorelin is a research peptide supplied for laboratory use only. While it has a clinical analog, this product is not approved for human use outside of licensed clinical settings. Handle in accordance with your institution's endocrine peptide research protocols and all applicable local regulations.

HPLC + massespektrometri-verificeret
Hver batch testes af tredjepart.
24-timers EU-afsendelse
Køle-pakket fra Antwerpen-lager. Typisk 2–5 dages levering.
Diskret og sikker betaling
iDEAL, SEPA, kort og krypto. Ingen produktreferencer på fakturaen.
CoA på hver ordre
Certificate of Analysis matchet til netop dit batch, via e-mail.

Ofte stillede spørgsmål

13 spørgsmål
Hvor hurtigt leverer I, og hvilke fragtfirmaer bruger I?
Ordrer afgivet inden kl. 16:00 CET afsendes samme hverdag fra Holland med DPD eller PostNL. Levering i EU tager typisk 2–5 hverdage og er altid sporet.
Hvilke betalingsmetoder accepterer I?
Vi accepterer iDEAL, Bancontact, Klarna, SEPA-straksoverførsel og Visa/Mastercard. Alle betalinger håndteres af PCI-DSS-godkendte europæiske udbydere.
Hvordan verificerer I peptidernes renhed?
Hvert batch HPLC-testes til 99 % renhed eller højere af et uafhængigt tredjeparts-laboratorium, med identitet bekræftet ved massespektrometri. Det batch-specifikke CoA offentliggøres på hver produktside.
Er forskningspeptider lovlige at købe i Danmark og EU?
Ja, når de sælges og købes udelukkende til in vitro-laboratorieforskning. Peptider på my\PEPT.eu er ikke godkendt eller beregnet til human eller veterinær brug.
Hvordan opbevares forskningspeptider?
Lyofiliserede peptider holder op til 24 måneder ved −20 °C. Når de er rekonstitueret i bakteriostatisk vand, opbevares de ved 2–8 °C og bruges inden for 28 dage.
Hvad er Tesamorelin som forskningspeptid?
Tesamorelin er en syntetisk analog af væksthormon-frigivende hormon (GHRH), bestående af den fulde 44-aminosyre GHRH-sekvens med en trans-3-hexensyre-modifikation ved N-terminus, hvilket giver en molekylvægt på ca. 5.135 Da. Det studeres i laboratorieforskning for dets bindingsaffinitet ved GHRH-receptoren. my\PEPT.eu leverer Tesamorelin udelukkende til in vitro-forskningsbrug — ikke til human eller veterinær konsum.
Hvordan opbevares Tesamorelin?
Lyofiliseret Tesamorelin er stabilt op til 24 måneder ved −20 °C i et forseglet hætteglas, beskyttet mod lys og fugt. Når det er rekonstitueret i bakteriostatisk vand til laboratoriebrug, opbevares ved 2–8 °C og bruges inden for 28 dage. Undgå gentagne frys/tø-cyklusser. Kun til forskningsbrug — ikke til human brug.
Hvad viser Certificate of Analysis for Tesamorelin?
Det batch-specifikke CoA for Tesamorelin bekræfter HPLC-renhed ≥99 %, sekvens-identitet ved massespektrometri, batch-nummer, netto peptid-indhold og vandindhold ved Karl Fischer-titrering. Kan downloades fra Tesamorelin-produktsiden. Ikke til human eller veterinær konsum.
What is tesamorelin?
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH) with the full 44-amino-acid sequence and an N-terminal trans-3-hexenoic acid modification that resists DPP-IV cleavage. It is studied in preclinical endocrine research. myPEPT supplies it lyophilised, strictly for laboratory research use only.
What is tesamorelin studied for in research?
Published preclinical work uses tesamorelin as a reference GHRH analogue in models of pulsatile GH-axis signalling, IGF-1 feedback loops and visceral-adipose pathway biology. These are laboratory models; the compound has not been evaluated for use in people and myPEPT makes no claims about effects in humans.
How does tesamorelin differ from native GHRH?
Both share the same 44-amino-acid sequence. Tesamorelin adds a trans-3-hexenoic acid group at the N-terminus, which blocks cleavage by the DPP-IV enzyme and gives the peptide a longer plasma stability than native GHRH. That stability is the main reason it is preferred in laboratory receptor studies.
How is tesamorelin purity verified?
Every batch is analysed by an independent third-party laboratory using HPLC and mass spectrometry and must reach at least 99% purity. The certificate of analysis is published on our lab results page, and the lot number on the certificate matches the lot number printed on the vial you receive.
Does myPEPT ship tesamorelin to Ireland and the rest of Europe?
Yes. Tesamorelin ships within Europe, including Ireland, with tracking on every parcel. Customers in Ireland can pay by card, PayPal, Klarna or SEPA transfer. The product is sold strictly for laboratory research use only and is not for human consumption.
⚠

For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use.